There was one instance (i.e., a combination of gene and cancer type) where RNA VAF repeatedly identified (Fisher’s exact test, p < 0.1) putative driver mutations among BoostDM passengers: KDM6A in urothelial carcinoma of the bladder. The gene discussed is KDM6A; the disease is bladder transitional cell carcinoma.